Pharmacists play a key role in guiding patients on GLP-1 and dual agonist therapies, supporting safe use, managing adverse effects, and promoting long-term treatment success.
Hailey Choi, PharmD, BCACP, CDCES
Advertisement
Articles by Hailey Choi, PharmD, BCACP, CDCES
Seven major clinical trials reveal semaglutide’s expanding benefits beyond glucose control, showing promise in kidney, heart, liver, vascular, and obesity-related outcomes.
In the first episode of the podcast, Jennifer Goldman and Hailey Choi discuss the latest FDA updates around compounded weight loss medications, clinical concerns and how pharmacists can protect their patients.
Advertisement
Latest Updated Articles
Wicked Good Cardiometabolic Chat: Semaglutide’s Expanding Role in Chronic DiseasePublished: July 15th 2025 | Updated:
- Wicked Good Cardiometabolic Chat: Practical Counseling Tips for GLP-1, Dual Agonist Therapies
Published: August 19th 2025 | Updated:
Advertisement
Advertisement
Trending on Drug Topics
1
American Pharmacists Month: Pharmacist Barriers, Expansion of Scope Since the COVID-19 Pandemic
2
Pass-Through Rebate Law Uncovering New PBM Tactics, Entities | NCPA 2025
3
Community Pharmacies Need to Better Prioritize Whole-Person Health Care | NCPA 2025
4
Automation Helps Pharmacies Maximize Revenue, Improve Patient Care | NCPA 2025
5
